Sodium pyrophosphate decahydrate
目录号 : GC66493Sodium pyrophosphate decahydrate 可作为缓冲剂、螯合剂和水合盐成核剂。Sodium pyrophosphate decahydrate 还可作为合成洗衣香味添加剂的原料。
Cas No.:13472-36-1
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Sodium pyrophosphate decahydrate can be as a buffering agent, a chelator and a hydrated salt nucleating agent. Sodium pyrophosphate decahydrate can also be used to a raw material for synthetic laundry scent additives[1][2].
[1]. Xin Xu, et al. Local Electric Field Modulated Reactivity of Pseudomonas aeruginosa Acid Phosphatase for Enhancing Phosphorylation of l-Ascorbic Acid. ACS Catal. 2021, 11, 21, 13397-13407.
[2]. Kai Luo, et al. Preparation and Thermal Performance Analysis of New Composite Phase Change Materials of Sodium Acetate Trihydrate and Different Additives. Volume7, Issue13. April 5, 2022. e202104346
Cas No. | 13472-36-1 | SDF | Download SDF |
分子式 | H20Na4O17P2 | 分子量 | 446.06 |
溶解度 | H2O : ≥ 50 mg/mL (112.09 mM) | 储存条件 | 4°C, away from moisture |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.2419 mL | 11.2093 mL | 22.4185 mL |
5 mM | 0.4484 mL | 2.2419 mL | 4.4837 mL |
10 mM | 0.2242 mL | 1.1209 mL | 2.2419 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Single-nucleotide polymorphism typing based on pyrosequencing chemistry and acryl-modified glass chip
Electrophoresis 2009 Mar;30(6):991-8.PMID:19235806DOI:10.1002/elps.200800395.
A new method (termed as "chip-BAMPER" (bioluminometric assay coupled with modified primer extension reactions)) for single-nucleotide polymorphism (SNPs) genotyping was developed by pyrosequencing chemistry coupled with hydrogel chip immobilized with single-stranded target DNAs. The method is based on allele-specific extension reaction, which is switched by the base type in the 3' end of allele-specific primers. A genotype is determined by comparing the light intensity from a pair of gel pads, and the specificity is improved by introducing an artificially mismatched base at the third position upstream from the 3' end of the allele-specific primer. The big problem of chip-BAMPER is the ultra-high background of the detection mixture because apyrase could not be used. Here, we successfully prepared and used beaded apyrase, which can be removed from the detection mixture before sample typing, to decrease the high background due to adenosine 5'-triphosphate and inorganic pyrophosphate or Sodium pyrophosphate decahydrate contamination. Unlike gel-based pyrosequencing, chip-BAMPER is highly sensitive because many bases are extended at a time in one extension reaction. Usually, less than 0.25 microL of PCR products can give a successful genotyping. To evaluate the method, four SNPs, OLR1-C15577T, OLR1-C14417G, PPARG-Pro12Ala, and PPARG-C2821T, were detected. To avoid the crosstalk between two adjacent spots in a gel-chip, mineral oil was dispensed to coat the gel-chip for physically separating two spots. It is shown that this new strategy of SNP typing based on the acryl-modified glass chip is highly sensitive, simple, inexpensive, and easy to be automated. It can be used for various applications of DNA analysis at a relative high-throughput.
Quantification of human plasma inorganic pyrophosphate. I. Normal values in osteoarthritis and calcium pyrophosphate dihydrate crystal deposition disease
Arthritis Rheum 1979 Aug;22(8):886-91.PMID:223577DOI:10.1002/art.1780220812.
The methodologic variables of the UDPG pyrophosphorylase method for analysis of inorganic pyrophosphate (PPi) levels in biologic fluids are described. Use of a tourniquet in collection of blood specimens elevated plasma PPi levels from 35% to 55% above control values and may explain the differences in published normal values. The Sodium pyrophosphate decahydrate used to prepare the standard solution lost 8 waters of hydration after dessication, which could result in the calculation of spuriously elevated PPi levels. Normal plasma PPi concentration was 2.18 muM with a range (95% confidence limits) of 0.58-3.78 muM. Comparison of plasma PPi in normal subjects, patients with primary osteoarthritis, and patients with calcium pyrophosphate dihydrate deposition disease revealed no significant intergroup differences.